Biogen C.E.O. to Step Down Following Launch of Alzheimer’s Drug, Aduhelm
The drug company will effectively give up on marketing Aduhelm, [...]
Sales of Biogen’s Alzheimer’s Drug Fall Short of Expectations
The drug, Aduhelm, brought in $300,000 in revenue in its [...]
Biogen’s Aduhelm Sales Total $2 Million in Second Quarter
The drug from Biogen, called Aduhelm, is expected to generate [...]